FLT vs STOK
FLT (FLT) versus Stoke Therapeutics Inc (STOK) — a side-by-side from cached financials, not a winner call.
FLT (FLT) common stock.
Stoke Therapeutics Inc (STOK) is a biotechnology company listed on NASDAQ.
FLT does not have a complete income-statement cache yet.
Latest reported STOK revenue for 2024-12-31 was $36.6M. Net income was -$89.0M. Revenue was up 316.3% from 2023-12-31 to 2024-12-31. STOK currently screens at market cap $1.88B.
STOK currently screens at market cap $1.88B.
Not investment advice. Open the FLT and STOK stock pages for the full models.
Not investment advice.